N B de Pinho1, R B Martucci2, V D Rodrigues3, C A D'Almeida4, L C S Thuler5, C Saunders6, H Jager-Wittenaar7, W A F Peres8. 1. Department of Nutrition and Dietetics, Institute of Nutrition, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Technical Support Division, Cancer Hospital Unit I, National Cancer Institute José Alencar Gomes da Silva, Rio de Janeiro, Brazil; Brazilian Society of Oncology Nutrition, Rio de Janeiro, Brazil. Electronic address: npinho@inca.gov.br. 2. Nutrition and Dietetic Service, Cancer Hospital Unit I, National Cancer Institute José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil; Nutrition Institute, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Brazil; Brazilian Society of Oncology Nutrition, Rio de Janeiro, Brazil. 3. Nutrition and Dietetic Service, Cancer Hospital Unit I, National Cancer Institute José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil; Brazilian Society of Oncology Nutrition, Rio de Janeiro, Brazil. 4. Nutrition and Dietetic Service, Cancer Hospital Unit I, National Cancer Institute José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil. 5. Clinical Research Division, Research Center, National Cancer Institute José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil. 6. Department of Nutrition and Dietetics, Institute of Nutrition, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. 7. Research Group Healthy Ageing, Allied Health Care and Nursing, Hanze University of Applied Sciences, Groningen, The Netherlands; Department of Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 8. Department of Nutrition and Dietetics, Institute of Nutrition, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Brazilian Society of Oncology Nutrition, Rio de Janeiro, Brazil.
Abstract
BACKGROUND & AIMS: Malnutrition in cancer is an independent factor associated with negative clinical outcomes. The aim was to evaluate the prevalence and independent risk factors for malnutrition in hospitalized cancer patients using the Patient-Generated Subjective Global Assessment (PG-SGA). METHODS: We evaluated 4783 cancer patients, aged ≥20 years, in a hospital-based, multicenter, cross-sectional study. Patients were classified as well-nourished (PG-SGA Stage A), moderate/suspected malnutrition (PG-SGA Stage B), or severely malnourished (PG-SGA Stage C), and provided a score to define required nutritional interventions. Multivariate analysis was composed of the odds ratio (OR) estimated by ordinal polytomous logistic regression. RESULTS: 45.3% were classified as Stage B and 11.8% as Stage C. Moreover, 45.3% of the patients presented a need for nutritional intervention. The variables that presented the highest ORs for Stage B or Stage C were: problems with swallowing (OR 2.8, 95% confidence interval (CI) 2.2-3.4, p < 0.001), loss of appetite (OR 1.9, 95% CI 1.6-2.3, p < 0.001), vomiting (OR 1.8, 95% CI 1.5-2.3, p < 0.001), presence of more than 3 nutrition impact symptoms (OR 8.3, 95% CI 5.8-12, p < 0.001), and cancer site: lung (OR 4.6, 95% CI 3.2-6.6, p < 0.001), upper digestive cancer (OR 3.7, 95% CI 2.7-5.2, p < 0.001), and head and neck cancer (OR 3.7, 95% CI 2.7-5.2, p < 0.001). The score for Worksheet 4 on the PG-SGA had a higher association with malnutrition (OR 7.3, 95% CI 6.6-8.2, p < 0.001). CONCLUSIONS: Malnutrition is highly prevalent in cancer patients in Brazil, and is associated with nutritional impact symptoms, cancer site and age ≥65 years.
BACKGROUND & AIMS:Malnutrition in cancer is an independent factor associated with negative clinical outcomes. The aim was to evaluate the prevalence and independent risk factors for malnutrition in hospitalized cancerpatients using the Patient-Generated Subjective Global Assessment (PG-SGA). METHODS: We evaluated 4783 cancerpatients, aged ≥20 years, in a hospital-based, multicenter, cross-sectional study. Patients were classified as well-nourished (PG-SGA Stage A), moderate/suspected malnutrition (PG-SGA Stage B), or severely malnourished (PG-SGA Stage C), and provided a score to define required nutritional interventions. Multivariate analysis was composed of the odds ratio (OR) estimated by ordinal polytomous logistic regression. RESULTS: 45.3% were classified as Stage B and 11.8% as Stage C. Moreover, 45.3% of the patients presented a need for nutritional intervention. The variables that presented the highest ORs for Stage B or Stage C were: problems with swallowing (OR 2.8, 95% confidence interval (CI) 2.2-3.4, p < 0.001), loss of appetite (OR 1.9, 95% CI 1.6-2.3, p < 0.001), vomiting (OR 1.8, 95% CI 1.5-2.3, p < 0.001), presence of more than 3 nutrition impact symptoms (OR 8.3, 95% CI 5.8-12, p < 0.001), and cancer site: lung (OR 4.6, 95% CI 3.2-6.6, p < 0.001), upper digestive cancer (OR 3.7, 95% CI 2.7-5.2, p < 0.001), and head and neck cancer (OR 3.7, 95% CI 2.7-5.2, p < 0.001). The score for Worksheet 4 on the PG-SGA had a higher association with malnutrition (OR 7.3, 95% CI 6.6-8.2, p < 0.001). CONCLUSIONS:Malnutrition is highly prevalent in cancerpatients in Brazil, and is associated with nutritional impact symptoms, cancer site and age ≥65 years.
Authors: Jenelle Loeliger; Sarah Dewar; Nicole Kiss; Allison Drosdowsky; Jane Stewart Journal: Support Care Cancer Date: 2021-03-12 Impact factor: 3.603
Authors: Nora Lize; Vera IJmker-Hemink; Rianne van Lieshout; Yvonne Wijnholds-Roeters; Manon van den Berg; Maggy Youssef-El Soud; Sandra Beijer; Natasja Raijmakers Journal: Support Care Cancer Date: 2021-04-21 Impact factor: 3.603
Authors: Iris M Y van Vliet; Antonio W Gomes-Neto; Margriet F C de Jong; Stephan J L Bakker; Harriët Jager-Wittenaar; Gerjan J Navis Journal: Eur J Clin Nutr Date: 2021-02-15 Impact factor: 4.884
Authors: Emanuelle do Nascimento Santos Lima; Isabela Borges Ferreira; Paula Philbert Lajolo; Carlos Eduardo Paiva; Yara Cristina de Paiva Maia; Geórgia das Graças Pena Journal: Health Qual Life Outcomes Date: 2020-09-16 Impact factor: 3.186